Reading the tape
NASDAQ: GNLX
Genelux Corporation
Healthcare · Biotechnology
Market Cap
$103.26M
52w High
$8.54
52w Low
$2.26
P/E
-3.17
Volume
46.22K
Outstanding Shares
37.62M
Price vs Fundamentals
Why The Stock Is Moving
Mixed / unclearLow confidence
Note: The most recent financial data is over 3 months old. Metrics shown may not reflect the latest reporting period.
1Y Price: 10.76%Revenue (TTM): 0%FCF (TTM): -22.01%
What changed
The stock rose 10.76% over the last year. Revenue was flat over the trailing twelve months. Operating margin moved from -396,200% to -415,175%. Free cash flow declined 22.01% over the trailing twelve months.
What the market seems to be pricing
The stock has moved higher against modestly weakening underlying metrics. The operating data does not yet tell a clear story — the move may reflect sentiment, sector rotation, or macro factors rather than company-specific earnings power.
What would invalidate this read
Operating margin currently stands at -415,175%. A decisive move in revenue — currently down 0% — would be the clearest signal to resolve the ambiguity.
Company profile
Genelux Corporation, a clinical-stage biopharmaceutical company, focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types.
CEOThomas D. Zindrick
SectorHealthcare
IndustryBiotechnology
Employees24
IPO dateJan 26, 2023
Valuation
Forward P/E—
EV/EBITDA-4.85
Enterprise value$158.44M
Stock splits
No stock splits recorded for this ticker.
Profitability & growth
Revenue growth—
Gross margin-3,537.5%▲36.76%vs FY2024
Operating margin-415,175%▼4.79%vs FY2024
ROE-278.46%▼144.94%vs FY2024
Analyst consensus
RatingBuy
Target price$17.33▲531.33%
2
Buy
1
Hold
0
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
May 5, 2026
Q2 FY26 · EPS est -$0.18 · Revenue est $6.78K
View